By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apricus Biosciences 

6330 Nancy Ridge Drive
Suite 103
San Diego  California  92121  U.S.A.
Phone: 858-222-8041 Fax: 858-866-0482


Drug Delivery

Company News
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014 1:15:18 PM
Apricus Biosciences (APRI) Expands Development Pipeline With The In-Licensing Of U.S. Rights For Fispemifene, A Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions In Men 10/20/2014 6:22:45 AM
Apricus Biosciences (APRI) Announces Notice Of Allowance Of U.S. Patent Application For Rayva™ 10/13/2014 7:54:48 AM
Apricus Biosciences (APRI) Biosciences To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 8:57:31 AM
Apricus Biosciences (APRI) CEO To Discuss Company's Drug Portfolio, Including Its Topical Cream For Erectile Dysfunction, Vitaros®, LIVE On Iheart (Clear Channel) Business Talk Radio DFW 1190AM On Sept. 25, 2014 9/26/2014 2:41:56 PM
Apricus Biosciences (APRI) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/3/2014 7:46:24 AM
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Germany By Hexal 8/18/2014 7:10:48 AM
Apricus Biosciences (APRI) Provides Corporate Update And Second Quarter 2014 Financial Results 8/12/2014 7:41:39 AM
Apricus Biosciences (APRI) Enters Into Common Stock Purchase Agreement With Aspire Capital 8/12/2014 7:40:33 AM
Apricus Biosciences (APRI) Announces Appointment Of Sandford D. Smith To Board Of Directors 8/11/2014 8:05:03 AM